Investigators opined, “CBD could represent a promising therapeutic perspective for patients with SCD suffering from chronic pain.”
Topic: CBD
“These encouraging results suggest that further multicenter, larger, randomized, controlled trials of longer-term are warranted.”
“To the best of our knowledge, this is the first study … regarding cannabis use in the medical context in ALS patients.”
“Few products had measured CBD concentrations within 10 percent of advertised concentrations, with most falling below advertised concentrations,” the study’s authors concluded.
The topical application of hemp-derived cannabinoids produced results that were superior to those associated with prescription treatments.
Edible products dominant in CBD were associated with greater improvements in pain intensity and sleep quality than were products high in THC
Investigators concluded that TS patients who consumed THC/CBD extracts daily experienced “a significant reduction in tics.”
Researchers concluded: “We suggest that CBD may be a more effective and safe choice for managing behavioral and psychological symptoms of dementia.”